That is necessary, since the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (jeff brown biotech stock). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're designed to do. This was an advancement almost no one saw. However it's going to have extensive implications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment chances in this area, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (tech stocks). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back perhaps substantially prior to going higher - jeff brown stock predictions 2021. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. However that's not the huge question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. genetic sequencing companies jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many terrific private companies on the verge of striking the public markets And I have actually been dealing with a new way for you to invest even prior to these companies go public.
This opportunity has been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your area totally free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers know that tech isn't our normal beat (jeff brown stock predictions 2021). And when it pertains to tech investing, we leave it to the specialists. Fortunately, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (jeff brown biotech pick). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and creating incredible opportunities for investors. I desire to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown tech stock 2021. But despite what many readers may believe, this is a trend that's simply starting. Although the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 2021 predictions). Losing 2 months of manufacturing and sales truly impacts how many 5G devices are sold in the calendar year. When you consider all of that, selling 250 million systems is impressive. More significantly, the hold-ups brought on by the pandemic developed a lots of bottled-up demand. Which demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be shipped in 2021 - jeff brown top biotech 2020. And that's not my only 5G forecast When I have actually talked about 5G in the past, I have actually explained its three different phases.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be provided (legacy report prediction). That's when we begin to see applications operating on 5G networks. Believe of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer season. This starts something of a virtuous cycle: The majority of people do not really care about the innovation. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open a suite of unbelievable applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities going forward will be huge. Stepping far from 5G, the next important innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were really just 3 companies running in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole industry is efficiently a greenfield chance.
There's room for numerous business to exist in this area. biotech stock. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary since the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug treatments produced utilizing this innovation. This was among those advancements that practically no one discovered. However it's going to have profound implications for treating disease. And, of course, there will be a lot of investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin - jeff brown top stock pick 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. united arab emirates. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we might not independently validate this claim. Provided Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to choose winning technology stocks. He invested more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an exceptional perspective on the market. He's constantly on the hunt for brand-new chances, and he shares a lot of his best choices in the Near Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively forecasted a few of the greatest financial events of the past 20 years. Although he does not appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it best each time, but Jeff Brown's accurate predictions have made him legions of devoted followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research study, a prominent monetary research publisher. Brownstone Research study uses numerous research services with a variety of expertises - jeff brown biotech pick.
The company is also associated with Bonner & Partners, another well-respected research publisher - last year. On its website, Brownstone states its objective is to supply retail investors with professional-grade research: "For too long, the very best financial investment research study has actually not been readily available to specific investors. It has actually been normally booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. united states. The mission of Brownstone Research study is to make that sort of exclusive research offered to any investors wanting to get an edge in the markets. The objective is simple to deliver distinct and lucrative investment research discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also functions as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After years of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout most of America. If you understand even a bit about the market, you know that he has a reputation as a King Midas of sorts. jeff bezos. Whatever he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. first lady. could be "the most significant trend of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two advanced innovations: expert system and electric cars and trucks. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's nothing except the vehicle industry's Holy Grail. As you know, electric cars and self-driving car stocks have been substantial this year, but the Wall Street device has actually been huge on buzz without much concrete result. In spite of an extreme increase in competitors over the previous few years, Brown still believes Musk has the finest chance of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would allow you to lease out your car as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the vehicle and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the earnings. It sounds insane, however it could be closed than you think.